Chronic kidney disease (CKD) is a progressive condition that begins with tissue damage and gradually leads to loss of kidney function. The condition, which affects about 10% of the global population, ...
The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
Practices need to look at all opportunities for preserving kidney function, according to the director of the Kidney Nutrition Institute. Models of value-based care (VBC) are being implemented across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback